Last reviewed · How we verify
Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer (HOPE)
SOLTI 1903 HOPE is a national, real world clinical practice study conducted in patients diagnosed with metastatic breast cancer who are receiving, have just received or will receive treatment for its advanced disease. Patients will lead their inclusion, participation and follow-up in the study through a digital tool, but they are encouraged to include their physician's in this study. Tissue samples from metastatic (preferred) or primary tumor will be collected for analyses, together with blood samples. A Molecular Advisory Board (MAB) will assess and give recommendations according patient's molecular profile. The primary objective is to assess the real-world clinical practice of integration of molecular profiling in the Standard of Care (SoC) management of mBC patients connected through a digital tool.
Details
| Lead sponsor | SOLTI Breast Cancer Research Group |
|---|---|
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 600 |
| Start date | Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Metastatic Breast Cancer
Interventions
- blood sample collection and collection of tumor tissue block
Countries
Spain